Olkem Trio 12.5 Tablet
Marketer
Alkem Laboratories Ltd
Salt Composition
Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Overview Olkem Trio 12.5 Tablet
Hypertrin-12.5, a triple-combination medication, is prescribed for hypertension when monotherapy proves insufficient. This formulation effectively lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Administer Hypertrin-12.5 with food, adjusting the dosage according to individual response and physician guidance. Maintain consistent daily timing. Continuous use, as directed by your doctor, is crucial. As it includes a diuretic, increased urination is expected; therefore, avoid dosing within four hours of bedtime. Consistent use, even during symptom-free periods, maximizes therapeutic benefits. Untreated hypertension is often asymptomatic; discontinuation elevates stroke and heart attack risk. Common side effects include ankle edema, cephalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your physician. Ample hydration is recommended to counter potential muscle weakness, xerostomia, and excessive thirst. Prior to initiating treatment, disclose any liver or kidney dysfunction. Pregnant or lactating individuals require physician consultation before use. Comprehensive disclosure of all concurrent medications, particularly those for hypertension or cardiac conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte levels, and blood glucose is necessary to ensure treatment efficacy.
Primary Ingredients of Olkem Trio 12.5 Tablet
No information provided. Please provide the text you want me to rewrite.
Uses of Olkem Trio 12.5 Tablet
Elevated blood pressure
Major Benefits of Olkem Trio 12.5 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olkem Trio 12.5mg tablets should be administered with food.
Common Side effects of Olkem Trio 12.5 Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Olkem Trio 12.5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olkem Trio 12.5 Tablets should be administered with a meal.
How Olkem Trio 12.5 Tablet works:
Olkem Trio 12.5mg tablets contain olmesartan medoxomil, cilnidipine, and chlorthalidone, three medications working synergistically to manage hypertension. Olmesartan medoxomil, an angiotensin II receptor antagonist, and cilnidipine, a calcium channel blocker, both promote vasodilation, reducing blood pressure. Chlorthalidone, a diuretic, facilitates fluid excretion, further lowering pressure and enhancing vascular function via its long-term effects on blood flow.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Olkem Trio 12.5mg tablets and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Olkem Trio 12.5 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided, except in critical circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Olkem Trio 12.5 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Olkem Trio 12.5 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olkem Trio 12.5 mg tablets, as dose modification may be necessary. Consult a physician before use; this medication is generally not advised for such individuals.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Olkem Trio 12.5 Tablet, potentially requiring a modified dosage. Physician consultation is advised. Olkem Trio 12.5 Tablet is contraindicated for patients exhibiting severe hepatic dysfunction.
What if you forget to take Olkem Trio 12.5 Tablet :
Should you forget a dose of Olkem Trio 12.5 Tablet, take it immediately if you remember. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Olkem Trio 12.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |






